An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor - Test2 - elhamkhani - TriplyDB

An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor

An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor

http://www.wikidata.org/entity/Q28249782

about

Kynurenines in CNS disease: regulation by inflammatory cytokines Remarkable role of indoleamine 2,3-dioxygenase and tryptophan metabolites in infectious diseases: potential role in macrophage-mediated inflammatory diseases The Aryl Hydrocarbon Receptor Relays Metabolic Signals to Promote Cellular Regeneration Mucosal Interactions between Genetics, Diet, and Microbiome in Inflammatory Bowel Disease Metabolic communication in tumors: a new layer of immunoregulation for immune evasion Understanding the role of the kynurenine pathway in human breast cancer immunobiology Targeting the indoleamine 2,3-dioxygenase pathway in cancer Kynurenine 3-Monooxygenase: An Influential Mediator of Neuropathology Signaling Circuits and Regulation of Immune Suppression by Ovarian Tumor-Associated Macrophages The Role of Indoleamine 2, 3-Dioxygenase in Immune Suppression and Autoimmunity T cell metabolism drives immunity The indoleamine 2,3-dioxygenase (IDO) pathway controls allergy Molecular pathways: trafficking of metabolic resources in the tumor microenvironment Development and survival of Th17 cells within the intestines: the influence of microbiome- and diet-derived signals The role of IDO in brain tumor immunotherapy The aryl hydrocarbon receptor meets immunology: friend or foe? A little of both The role of the aryl hydrocarbon receptor in normal and malignant B cell development Dendritic cell vaccination, immune regulation, and clinical outcomes in ovarian cancer Metabolic reprogramming and metabolic dependency in T cells Coactivator recruitment of AhR/ARNT1 The aryl hydrocarbon receptor: a molecular pathway for the environmental control of the immune response Aryl hydrocarbon receptor control of adaptive immunity Kynurenines in the mammalian brain: when physiology meets pathology IDO2 in Immunomodulation and Autoimmune Disease Trial watch: IDO inhibitors in cancer therapy Organ-specific and memory treg cells: specificity, development, function, and maintenance Indoleamine 2,3 dioxygenase in intestinal disease Structure and Dimerization Properties of the Aryl Hydrocarbon Receptor PAS-A Domain A Proton Wire and Water Channel Revealed in the Crystal Structure of Isatin Hydrolase Immunometabolism of regulatory T cells The role of Fatty Acid oxidation in the metabolic reprograming of activated t-cells Targeted immune therapy of ovarian cancer The Aryl Hydrocarbon Receptor: A Key Bridging Molecule of External and Internal Chemical Signals Changing the face of kynurenines and neurotoxicity: therapeutic considerations Molecular basis for catalysis and substrate-mediated cellular stabilization of human tryptophan 2,3-dioxygenase The Role of the Microbial Metabolites Including Tryptophan Catabolites and Short Chain Fatty Acids in the Pathophysiology of Immune-Inflammatory and Neuroimmune Disease The aryl hydrocarbon receptor-activating effect of uremic toxins from tryptophan metabolism: a new concept to understand cardiovascular complications of chronic kidney disease The role of AHR-inducible cytochrome P450s in metabolism of polyunsaturated fatty acids The Intercellular Metabolic Interplay between Tumor and Immune Cells An aryl hydrocarbon receptor induces VEGF expression through ATF4 under glucose deprivation in HepG2

P2860

Q21129356-AF74412F-6892-4A72-90C5-1AB8996BA9BA Q21285076-0FFA5CC3-238F-4CFC-8CDE-0B4794AD207D Q26738807-F9685FF3-1A12-44DF-B99E-FD6D7759E373 Q26741117-EF5F4321-CBE3-4ED8-ADF3-008281459DEF Q26765256-1F160504-28A4-4E3C-BF7E-EBCDA76AD3A2 Q26773472-B9E76B87-9EBD-4D31-85EF-4E576B19B89A Q26775471-0FA709E3-1595-4E42-A93C-B0E65C03B840 Q26782867-BEDBFF43-2ECA-4230-968B-9D35095544BD Q26783748-08677FBD-F132-497A-B0D6-457D42B1B7FE Q26785900-9EEE1D36-F93A-40B3-838F-932F687AFF60 Q26799575-3C684FFE-1DAE-4E23-B23A-E44DAFBC7634 Q26822976-7545C693-BC24-40F2-B831-27301661DF72 Q26825620-26E31660-A0BC-433F-B592-ED47B8B1D52B Q26829933-09DB33E4-A508-4747-8CC7-8C54DC7102BD Q26830399-1E8D0AEC-25B8-49FB-B580-23112259E223 Q26851740-F5A7C429-2757-46C3-BB39-838FF8DB52B5 Q26859116-C0DDF840-709C-4D6A-96BC-F42ECF66A512 Q26861293-D40CB9F1-FA9D-497E-995D-5C0F7487D8AD Q26864319-DC3F4725-8936-4539-8D8D-056FE35A22F6 Q26991590-630FBF28-E24F-4D81-A10C-7F81D8527C4D Q26991621-20DD846F-B69B-4FA3-8496-7E444A608A4B Q26991793-3874D544-DD3C-4935-B62D-3817F2E4A210 Q27003296-1F027570-AA64-457C-BC99-E4388E45DB36 Q27006786-48C3DAF4-3B5A-45EC-B64E-C9C30DA42C46 Q27006866-3DCA7267-99CF-4128-B648-50E2B1BCBF10 Q27010198-6FA1AD24-A749-443D-89BF-77D53B5AB1C9 Q27025063-44BEBCF8-243C-4E15-ADED-9D5DF8C06567 Q27679862-708A98C5-03D0-4186-AB66-7A383F963A6E Q27684294-CA08BDC6-2499-406D-8D0B-39388FDA4BBA Q28074509-A0D9BCC0-16D7-4761-B57C-BC70DD52A0EB Q28080686-61B11C90-CEB1-4688-B0C5-9893B3977E80 Q28082828-94B773AC-7AD5-45DF-BC6D-B78E39EA2A24 Q28083139-539E7281-0E06-457B-9A7E-CE0F4FF45E92 Q28085041-230743C4-5667-4548-91A4-51C549BF73E5 Q28115713-CB37DEE1-161B-4AD2-AF32-945AE66E4C7F Q28276657-1A32D265-8AA9-48B7-B27D-7010F767A271 Q28382992-7E19B43B-808A-4B48-B1F2-72A06A7C3D57 Q28389473-8B43B2D3-8200-4BBC-9700-EF883D27F700 Q28391079-A36B081A-8650-4412-87C2-CCCE0213DA86 Q28393127-BD971D2D-D2AF-4852-B6F4-B37635C51961

P2860

An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor

http://www.wikidata.org/entity/Q28249782

description

2011 nî lūn-bûn

@nan

2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

name

An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor

@ast

An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor

@en

An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor

@nl

type

label

An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor

@ast

An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor

@en

An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor

@nl

prefLabel

An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor

@ast

An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor

@en

An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor

@nl

P1433

Q28249782-968A53BB-1DA0-4F27-A11E-495B3A46294A

P1476

Q28249782-09AB27E3-4B08-4157-87F8-D814593786A2

P2093

Q28249782-1156AF98-4035-4C55-B327-F27832A65305

Q28249782-1AC8DC57-D468-40E6-BFE4-44A22A25C3BF

Q28249782-1AFBE1C6-3C52-42CD-A21F-CE73A431965E

Q28249782-2CB809CA-E003-4BA3-8AFB-ADF87EEACCA6

Q28249782-82452017-EF1E-4A1D-8317-2BC87E604B0E

Q28249782-8DD3785A-96A3-490C-8B5A-F1237E11DD27

Q28249782-9ED3E16E-389C-4F16-9CAA-36BF000327E9

Q28249782-9FEACD21-6D82-4618-9E4C-2DCAD1013DAA

Q28249782-DCA24501-F177-42A8-A859-0F78AE2BAECD

Q28249782-EB4C39CC-AEC8-40EB-B2FF-A4C9E5218E9C

P2888

Q28249782-A28B6C5E-637B-48E2-811C-E2E850938514

P304

Q28249782-653E7EF4-D5BA-483A-BBBB-D113694A186A

P31

Q28249782-F96C64B7-A1F6-4CB0-8D6C-222A98BC9CBA

P3181

Q28249782-52F732BD-9EA6-4C2B-82EA-45FC0D97DD2C

P356

Q28249782-22D78C8F-4F2D-4A65-BA71-B076D63ED3F0

P407

Q28249782-1DC3C07D-E2F1-4EBB-954F-900A42E34977

P433

Q28249782-2E090C57-83FD-41FC-B27E-418032500FE2

P478

Q28249782-608947F9-441E-4EB6-916D-E6D8643F7B93

P50

Q28249782-0320608E-E63E-4074-88CC-0BBA7224C235

Q28249782-06C7139B-EDA8-478E-8E69-CBED406DA0FC

Q28249782-45B88D19-133C-44DB-BE81-0CFC0F262D0E

Q28249782-48BDC04D-D7A4-455E-ACF6-F71D2C4BC00F

Q28249782-51C92469-B9A8-4B4B-8F89-6F3FF2525630

Q28249782-6E05D66F-79A5-418E-B769-1E5954E2EC80

Q28249782-763E837D-AE9F-4882-B44F-FFF02BEDFFC0

Q28249782-7FEA8A4A-C5E3-45F5-9590-5F1FFD94D932

P577

Q28249782-DF610BAC-0FA2-4C7C-8A8F-B347FB03E522

P5875

Q28249782-858A36BD-142C-4C62-A762-554CDFD6FD68

P6179

Q28249782-BEB4B848-309F-4851-A23E-D1630400BB0B

P698

Q28249782-0E423A12-84F7-4C40-AD65-9CE67C0CD231

P3181

P356

P1433

P1476

An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor

@en

P2093

Christian Lutz

http://www.w3.org/2001/XMLSchema#string

Christine L Miller

http://www.w3.org/2001/XMLSchema#string

Dieter Schrenk

http://www.w3.org/2001/XMLSchema#string

Irina Lehmann

http://www.w3.org/2001/XMLSchema#string

Isabel Tritschler

http://www.w3.org/2001/XMLSchema#string

Leonie Jestaedt

http://www.w3.org/2001/XMLSchema#string

Manfred Jugold

http://www.w3.org/2001/XMLSchema#string

Martina Ott

http://www.w3.org/2001/XMLSchema#string

Saskia Trump

http://www.w3.org/2001/XMLSchema#string

Theresa Schumacher

http://www.w3.org/2001/XMLSchema#string

P2888

P304

197-203

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

548889

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NATURE10491

http://www.w3.org/2001/XMLSchema#string

P407

P433

7368

http://www.w3.org/2001/XMLSchema#string

P478

478

http://www.w3.org/2001/XMLSchema#string

P50

Bernhard Radlwimmer

Gilles J. Guillemin

Michael Platten

Andreas von Deimling

Christiane Opitz

P577

2011-10-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51696102

http://www.w3.org/2001/XMLSchema#string

P6179

1002910234

http://www.w3.org/2001/XMLSchema#string

P698

21976023

http://www.w3.org/2001/XMLSchema#string